|

Sabestomig Clinical Trials

2 actively recruiting trials across 1 location

Also known as: AZD7789

Pipeline

Early 1: 2

Top Sponsors

  • Presage Biosciences2

Indications

  • Cancer2
  • Head and Neck Squamous Cell Carcinoma1
  • Solid Tumor1
  • Breast Cancer1

Sacramento, California2 trials

PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC

UC Davis

Early 1
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

UC Davis

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.